Plasma lipids predict myocardial infarction, but not stroke, in patients with established cerebrovascular disease.
暂无分享,去创建一个
M. Woodward | S. MacMahon | J. Chalmers | B. Neal | Anushka Patel | D. Sullivan | D. Campbell | S. Colman | D. Campbell
[1] R. Collins,et al. Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20 536 people with cerebrovascular disease or other high-risk conditions , 2004, The Lancet.
[2] C. Anderson,et al. Ten-Year Risk of First Recurrent Stroke and Disability After First-Ever Stroke in the Perth Community Stroke Study , 2004, Stroke.
[3] Progress. Effects of a Perindopril-Based Blood Pressure–Lowering Regimen on Disability and Dependency in 6105 Patients With Cerebrovascular Disease A Randomized Controlled Trial , 2003 .
[4] M. Hennerici,et al. Design and Baseline Characteristics of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Study , 2003, Cerebrovascular Diseases.
[5] Mark Woodward,et al. Cholesterol, coronary heart disease, and stroke in the Asia Pacific region. , 2003, International journal of epidemiology.
[6] M. Woodward,et al. Effects of a perindopril-based blood pressure lowering regimen on cardiac outcomes among patients with cerebrovascular disease. , 2003, European heart journal.
[7] Konrad Jamrozik,et al. Long-Term Disability After First-Ever Stroke and Related Prognostic Factors in the Perth Community Stroke Study, 1989–1990 , 2002, Stroke.
[8] H. Tunstall-Pedoe,et al. The prevalence of treatable left ventricular systolic dysfunction in patients who present with noncardiac vascular episodes: a case-control study. , 2002, Journal of the American College of Cardiology.
[9] R. D'Agostino,et al. Risk of Hospitalized Stroke in Men Enrolled in the Honolulu Heart Program and the Framingham Study: A Comparison of Incidence and Risk Factor Effects , 2002, Stroke.
[10] R. Sacco,et al. Mortality and causes of death after first ischemic stroke , 2001, Neurology.
[11] R. Sacco,et al. Mortality and causes of death after first ischemic stroke: The Northern Manhattan Stroke Study , 2001 .
[12] D. Johnston. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack , 2001, The Lancet.
[13] M. Woodward,et al. Randomised trial of a perindopril-based blood pressure lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack , 2001 .
[14] J. Egido,et al. Neurosonology in Cerebral Ischemia: Future Application of Transcranial Doppler in Acute Stroke , 2001, Cerebrovascular Diseases.
[15] B. Davis,et al. Reduction of Stroke Events With Pravastatin: The Prospective Pravastatin Pooling (PPP) Project , 2001, Circulation.
[16] S. Ebrahim,et al. HDL-Cholesterol, total cholesterol, and the risk of stroke in middle-aged British men. , 2000, Stroke.
[17] D. Albanes,et al. Different risk factors for different stroke subtypes: association of blood pressure, cholesterol, and antioxidants. , 1999, Stroke.
[18] R. Collins,et al. Underestimation of risk associations due to regression dilution in long-term follow-up of prospective studies. , 1999, American journal of epidemiology.
[19] Mark Woodward,et al. Epidemiology: Study Design and Data Analysis , 1999 .
[20] D. Jacobs,et al. Low total serum cholesterol and intracerebral hemorrhagic stroke: is the association confined to elderly men? The Kaiser Permanente Medical Care Program. , 1996, Stroke.
[21] L. Hansson. Blood pressure lowering for the secondary prevention of stroke: rationale and design for PROGRESS , 1996, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.
[22] G. Boysen,et al. Influence of total cholesterol, high density lipoprotein cholesterol, and triglycerides on risk of cerebrovascular disease: the Copenhagen city heart study , 1994, BMJ.
[23] R. Collins,et al. Blood pressure, stroke, and coronary heart disease Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context , 1990, The Lancet.
[24] R. Collins,et al. Blood pressure, stroke, and coronary heart disease Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias , 1990, The Lancet.
[25] D. Reed,et al. Serum cholesterol and hemorrhagic stroke in the Honolulu Heart Program. , 1989, Stroke.
[26] D. Jacobs,et al. Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the multiple risk factor intervention trial. , 1989, The New England journal of medicine.
[27] Simon Davies,et al. Epidemiology: Study Design and Data Analysis (2nd ed.) , 2006 .
[28] M. Woodward,et al. The Asia Pacific Cohort Studies Collaboration , 2003 .
[29] J. Chalmers. Perindopril Protection Against Recurrent Stroke Study (PROGRESS) , 2001 .
[30] R. Hirsch,et al. Stroke in China (Sino-MONICA-Beijing study) 1984-1986. , 1992, Neuroepidemiology.
[31] G. Moneta. Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20 536 people with cerebrovascular disease or other high-risk conditions Heart , 2022 .